Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo

European Journal of Immunology

Volumn 41, Issue 11, 2011, Pages 3208-3218

  Wex, Eva ^a   Bouyssou, Thierry ^a   Duechs, Matthias J ^a   Erb, Klaus J ^a   Gantner, Florian ^a   Sanderson, Michael P ^b   Schnapp, Andreas ^a   Stierstorfer, Birgit E ^a   Wollin, Lutz ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

Inducible knockout mice; Mast cells; Monocytes; Neutrophils; Syk

Indexed keywords

PROTEIN KINASE SYK; TAMOXIFEN;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL MIGRATION; CONTROLLED STUDY; GENE DELETION; GENE INACTIVATION; IN VIVO STUDY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SEPARATION; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; HYPERSENSITIVITY; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 80054885802     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141502     Document Type: Article

References (35)

1. Oliver, J. M., Burg, D. L., Wilson, B. S., McLaughlin, J. L. and Geahlen, R. L., Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem. 1994. 269: 29697-29703.
2. Kepley, C. L., Wilson, B. S. and Oliver, J. M., Identification of the Fc epsilonRI-activated tyrosine kinases Lyn, Syk, and Zap-70 in human basophils. J. Allergy Clin. Immunol. 1998. 102: 304-315.
3. Lach-Trifilieff, E., Menear, K., Schweighoffer, E., Tybulewicz, V. L. and Walker, C., Syk-deficient eosinophils show normal interleukin-5-mediated differentiation, maturation, and survival but no longer respond to FcgammaR activation. Blood 2000. 96: 2506-2510.
4. Mocsai, A., Zhou, M., Meng, F., Tybulewicz, V. L. and Lowell, C. A., Syk is required for integrin signaling in neutrophils. Immunity 2002. 16: 547-558.
5. Crowley, M. T., Costello, P. S., Fitzer-Attas, C. J., Turner, M., Meng, F., Lowell, C., Tybulewicz, V. L. and DeFranco, A. L., A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J. Exp. Med. 1997. 186: 1027-1039.
6. Mocsai, A., Humphrey, M. B., Van Ziffle, J. A., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S. et al., The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 2004. 101: 6158-6163.
7. Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J. P. and Tybulewicz, V. L., Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today 2000. 21: 148-154.
8. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B. and Pawson, T., Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995. 378: 303-306.
9. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L. and Tybulewicz, V. L., Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995. 378: 298-302.
10. Robinson, M. J., Osorio, F., Rosas, M., Freitas, R. P., Schweighoffer, E., Gross, O., Verbeek, J. S. et al., Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 2009. 206: 2037-2051.
11. Van Ziffle, J. A. and Lowell, C. A., Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. Blood 2009. 114: 4871-4882.
12. Wang, X., Lau, C., Wiehler, S., Pow, A., Mazzulli, T., Gutierrez, C., Proud, D., and Chow, C. W., Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells. J. Immunol. 2006. 177: 6859-6870.
13. Ruzza, P., Biondi, B., and Calderan, A., Therapeutic prospect of Syk inhibitors. Exp. Opin. Ther. Pat. 2009. 19: 1361-1376.
14. Ulanova, M., Duta, F., Puttagunta, L., Schreiber, A. D., and Befus, A. D., Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis. Exp. Opin. Ther. Targets 2005. 9: 901-921.
15. Mocsai, A., Ruland, J., and Tybulewicz, V. L., The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat. Rev. Immunol. 2010. 10: 387-402.
16. Denyer, J. and Patel, V., Syk kinase inhibitors in allergic diseases. Drug News Perspect. 2009. 22: 146-150.
17. Jakus, Z., Simon, E., Balazs, B., and Mocsai, A., Genetic deficiency of Syk protects mice from autoantibody-induced arthritis. Arthritis Rheum. 2010. 62: 1899-1910.
18. Schymeinsky, J., Sindrilaru, A., Frommhold, D., Sperandio, M., Gerstl, R., Then, C., Mocsai, A. et al., The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for beta2 integrin (CD11/CD18)-mediated neutrophil migration. Blood 2006. 108: 3919-3927.
19. Seibler, J., Zevnik, B., Kuter-Luks, B., Andreas, S., Kern, H., Hennek, T., Rode, A., et al., Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003. 31: e12.
20. Saijo, K., Schmedt, C., Su, I. H., Karasuyama, H., Lowell, C. A., Reth, M., Adachi, T. et al., Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat. Immunol. 2003. 4: 274-279.
21. Yamamoto, N., Takeshita, K., Shichijo, M., Kokubo, T., Sato, M., Nakashima, K., Ishimori, M. et al., The orally available spleen tyrosine kinase inhibitor 2-[7-(3, 4-dimethoxyphenyl)-imidazo[1, 2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. J. Pharmacol. Exp. Ther. 2003. 306: 1174-1181.
22. Cha, H. S., Boyle, D. L., Inoue, T., Schoot, R., Tak, P. P., Pine, P. and Firestein, G. S., A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes. J. Pharmacol. Exp. Ther. 2006. 317: 571-578.
23. Gevrey, J. C., Isaac, B. M. and Cox, D., Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J. Immunol. 2005. 175: 3737-3745.
24. Park, H. and Cox, D., Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages. J. Biol. Chem. 2011. 286: 14762-14769.
25. Stenton, G. R., Ulanova, M., Dery, R. E., Merani, S., Kim, M. K., Gilchrist, M., Puttagunta, L. et al., Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase. J. Immunol. 2002. 169: 1028-1036.
26. Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H., Downward, J., and Tybulewicz, V. L., Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 1996. 13: 2595-2605.
27. Matsubara, S., Koya, T., Takeda, K., Joetham, A., Miyahara, N., Pine, P., Masuda, E.S., Swasey, C. H., and Gelfand, E. W., Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation. Am. J. Respir. Cell Mol. Biol. 2006. 34: 426-433.
28. Matsubara, S., Li, G., Takeda, K., Loader, J. E., Pine, P., Masuda, E. S., Miyahara, N. et al., Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2006. 173: 56-63.
29. Cambien, B., Pomeranz, M., Millet, M. A., Rossi, B. and Schmid-Alliana, A., Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood 2001. 97: 359-366.
30. Schymeinsky, J., Mocsai, A. and Walzog, B., Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb. Haemost. 2007. 98: 262-273.
31. Zarbock, A., Lowell, C.A. and Ley, K., Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 2007. 26: 773-783.
32. Letellier, E., Kumar, S., Sancho-Martinez, I., Krauth, S., Funke-Kaiser, A., Laudenklos, S., Konecki, K. et al., CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 2010. 32: 240-252.
33. Zhang, Y., Ramos, B. F. and Jakschik, B. A., Augmentation of reverse arthus reaction by mast cells in mice. J. Clin. Invest 1991. 88: 841-846.
34. Nigrovic, P. A., Binstadt, B. A., Monach, P. A., Johnsen, A., Gurish, M., Iwakura, Y., Benoist, C. et al., Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc. Natl. Acad. Sci. USA 2007. 104: 2325-2330.
35. Wollin, L. and Pieper, M. P., Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm. Pharmacol. Ther. 2010. 23: 345-354.